About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT01538082

Role of the Stress in the Development of the Metabolic Syndrome

The purpose of this study is determine the incidence of metabolic syndrome (MetS) in people of high risk, of 40 or more years and attended in the Primary Care. Evaluating the association between anxie...

Lead sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Cecilia Borau

CONTACT

934824124 cborau@idiapjgol.org

Sponsors

Lead Sponsor

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

Collaborators

Societat Catalana de Medicina Familiar i Comunitària, Assoc. (CAMFiC)
Spanish Society of Family and Community Medicine

Age

40 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Both genders, elderly than 40 years
•Subjects with 1 or 2 criteria of NCEP-ATPIII set for Metabolic Syndrome
•* Abdominal waist \> 102 cm ( men ) or \>88 cm ( women )
•* Blood Pressure ( \>130/85 mmHg ) ( or else pharmacologic treatment of hypertension )
•* Hypertriglyceridaemia ( \>150 mg/dl ) ( or else pharmacologic treatment )
•* HDL-cholesterol \<40 mg/dl ( men ) or \<50 mg/dl ( women ) ( or else treatment )
•* Fasting glucose \> 110 mg/dl.

Exclusion Criteria

•Metabolic Syndrome (NCEP-ATPIII defined)(3 criteria of above mentioned)
•Severe or terminal disease
•Severe mental disease that difficulties the follow-up

Related studies

The Mom and Infant Outcomes (MOMI) Study

NCT06277661 · Postpartum Depression, Postpartum Anxiety, and more

Efficacy of a Transdiagnostic Group Treatment for Emotional Disorders Applied in Blended Format: a Controlled Study.

NCT05569018 · Anxiety Disorders, Depressive Disorders

The Impact of Melatonin Lotion on Sleep and Mental Health

NCT06768749 · Sleep Problems, Depressive Disorder and Anxiety Disorders

DINO RCT - Treating Anxiety in Children With Autism

NCT06066983 · Autism Spectrum Disorder, Anxiety Disorders

Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome

NCT07547098 · Cardiovascular Diseases (CVD), Chronic Kidney Disease, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 23, 2012Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment738

Start dateDec 2008

Last updatedFeb 23, 2012

Condition

Anxiety Disorders Depressive Disorders Metabolic Syndrome Stress Disorders

Locations shown

Catalan Health Institute. ABS Reus-4

Reus, Tarragona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 23, 2012Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions